Compare Match Group Inc (MTCH) vs Tempus AI (TEM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Match Group Inc vs Tempus AI — how do they compare? Match Group Inc trades at $41.46 (market cap $9.45B), while Tempus AI trades at $60.43 (market cap $11.67B). The key difference: Tempus AI is the larger of the two by market cap, and Match Group Inc pays a 1.94% dividend while Tempus AI pays none. Which is the better fit depends on your goals.
| MTCH | TEM | |
|---|---|---|
Market Cap | $9.45B | $11.67B |
Sector | Media | Broad Market / Factor |
52-Week High | $42.44 | $103.25 |
52-Week Low | $28.90 | $41.55 |
Enterprise Value | $12.41B | $12.30B |
Dividend Yield | 1.94% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MTCH trades at $41.15, down 1.7% today, near its consensus price target of $42.50. The stock shows a bullish technical signal with support at $41 and resistance at $42. Recent earnings beat expectations in Q2 2026, with Q3 2026 results pending. Revenue stability around $3.5B and a net income margin of 20.17% reflect solid profitability, though high debt levels pose a risk. Analysts are overwhelmingly positive with 53% buy ratings and no sell recommendations.
The outlook for MTCH is cautiously optimistic, driven by product innovation at Tinder and strong cash flow growth. Investment opportunities include potential upside to the $45 high price target and dividend payments. Risks include elevated long-term debt of $3.85B and competitive pressures in the dating app market. Investors should monitor Q3 2026 earnings for confirmation of growth trends.
Tempus AI (TEM) trades at $64.29, down 0.51% on the day, with a bullish technical signal and strong analyst support. The stock shows consistent earnings beats despite negative profitability, with a P/S of 7.99 and P/B of 26.23. Recent catalysts include FDA clearance for an AI ECG product and a $9.5 million ARPA-H award for autonomous AI in cardiology (Business Wire, September 9, 2026).
Outlook remains positive given analyst consensus and growth in precision medicine, but risks include sustained losses, high valuation multiples, and cash burn. The consensus price target is $69.11, implying potential upside, though investors must weigh the company's unprofitability against its innovation pipeline and market position.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Match Group Inc
Match Group is a provider of online dating products. The firm became public in 2015 and was more than 80% owned by IAC/InterActiveCorp until IAC spun it off in the second quarter of 2020. The company has a vast portfolio of different online dating service providers, including Tinder, Match.com, OkCupid, Plenty of Fish, and Meetic. Match Group has more than 45 brands of online dating sites and/or apps, from which it generates user fee revenue (95%) and advertising revenue (5%).
Read more on MTCH →About Tempus AI
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Read more on TEM →
